About Company:
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries. The company has 25 manufacturing and packaging facilities that are approved by leading regulatory agencies including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. The company’s robust product portfolio is spread over 7 major therapeutic/product areas encompassing CNS, Antiretroviral, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.
Vacancy Details:
Job Description:
𝐄𝐦𝐩𝐨𝐰𝐞𝐫 𝐘𝐨𝐮𝐫 𝐂𝐚𝐫𝐞𝐞𝐫 𝐰𝐢𝐭𝐡 𝐀𝐮𝐫𝐨𝐛𝐢𝐧𝐝𝐨 𝐏𝐡𝐚𝐫𝐦𝐚 𝐋𝐭𝐝! 𝐖𝐚𝐥𝐤-𝐢𝐧 𝐃𝐫𝐢𝐯𝐞 𝐟𝐨𝐫 𝐄𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬
Are you a skilled Pharma professional looking for your next big opportunity? Aurobindo Pharma Ltd is conducting a special Walk-in Drive to strengthen our team at Unit XV, Parawada, Visakhapatnam.
We are seeking passionate and experienced individuals for the following roles:
1.𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐃𝐞𝐩𝐚𝐫𝐭𝐦𝐞𝐧𝐭
Positions: Technical Assistant & Executives
Qualifications: B.Sc / Diploma / ITI (for Technical Assistant), B.Pharmacy / M.Pharmacy (for Executives)
Experience: 3-6 years
Area of Exposure: Compression, Granulation, Capsule Filling.
2.𝐏𝐚𝐜𝐤𝐢𝐧𝐠 𝐃𝐞𝐩𝐚𝐫𝐭𝐦𝐞𝐧𝐭
Positions: Technical Assistant & Executives
Qualifications: B.Sc / Diploma / ITI (for Technical Assistant), B.Pharmacy / M.Pharmacy (for Executives)
Experience: 2-6 years
Area of Exposure: OSD Secondary Packing, Cartonation.
How to Apply?
📍 𝐖𝐚𝐥𝐤-𝐢𝐧 𝐈𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
Date: Sunday, August 10, 2025
Time: 09:00 AM to 05:00 PM
Venue: Aurobindo Pharma Ltd, Unit III, Bachupally, Hyderabad
Please bring the following documents:
Updated Resume
All Educational Documents
PAN Card & Aadhar Card
Recent Increment Letter with CTC
Last 3 Months Payslips & Bank Statement
